newsfilter
← Latest News
GlobeNewswire·

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX:VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery